Regenerative medicine unites doctors, scientists, engineers, and others to accelerate healing processes.
Part three of this series discusses the key defenses available to each element of a lawsuit against providers and labs.
Part II reviews some lessons learned as we try to predict the trajectory and defenses to COVID-19 test cases.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
For medical device manufacturers, the American Invents Act created several challenges related to patent marking.
As additive manufacturing comes to the forefront as a disruptive technology, industry continues to speculate about how liability will be shared.
Requiring clear supplier agreements can force some tough conversations. Acme Monaco’s Lucas Karabin, and Hogan Lovells attorney Jodi Scott, discuss the importance for such agreements, and what they should ideally cover.